Bioteque Stock Current Valuation

4107 Stock  TWD 126.00  1.00  0.79%   
Valuation analysis of Bioteque helps investors to measure Bioteque's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Fairly Valued
Today
126.00
Please note that Bioteque's price fluctuation is very steady at this time. Calculation of the real value of Bioteque is based on 3 months time horizon. Increasing Bioteque's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Bioteque stock is determined by what a typical buyer is willing to pay for full or partial control of Bioteque. Since Bioteque is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Bioteque Stock. However, Bioteque's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  126.0 Real  126.63 Hype  126.0 Naive  124.01
The intrinsic value of Bioteque's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Bioteque's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
125.97
Downside
126.62
Real Value
127.29
Upside
Estimating the potential upside or downside of Bioteque helps investors to forecast how Bioteque stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Bioteque more accurately as focusing exclusively on Bioteque's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
125.64126.36127.09
Details
Hype
Prediction
LowEstimatedHigh
125.34126.00126.66
Details
Naive
Forecast
LowNext ValueHigh
123.35124.01124.67
Details

Bioteque Company Current Valuation Analysis

Bioteque's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current Bioteque Current Valuation

    
  7.75 B  
Most of Bioteque's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bioteque is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, Bioteque has a Current Valuation of 7.75 B. This is 46.04% lower than that of the Healthcare sector and 15.23% lower than that of the Medical Instruments & Supplies industry. The current valuation for all Taiwan stocks is 53.38% higher than that of the company.

Bioteque Current Valuation Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bioteque's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Bioteque could also be used in its relative valuation, which is a method of valuing Bioteque by comparing valuation metrics of similar companies.
Bioteque is currently under evaluation in current valuation category among its peers.

Bioteque Fundamentals

About Bioteque Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Bioteque's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bioteque using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bioteque based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Pair Trading with Bioteque

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bioteque position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bioteque will appreciate offsetting losses from the drop in the long position's value.

Moving together with Bioteque Stock

  0.646491 PegavisionPairCorr

Moving against Bioteque Stock

  0.716763 Green World FintechPairCorr
  0.661565 StShine OpticalPairCorr
  0.650050 YuantaP shares TaiwanPairCorr
  0.650057 Fubon MSCI TaiwanPairCorr
  0.610053 YuantaP shares TaiwanPairCorr
The ability to find closely correlated positions to Bioteque could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bioteque when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bioteque - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bioteque to buy it.
The correlation of Bioteque is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bioteque moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bioteque moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bioteque can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for Bioteque Stock Analysis

When running Bioteque's price analysis, check to measure Bioteque's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioteque is operating at the current time. Most of Bioteque's value examination focuses on studying past and present price action to predict the probability of Bioteque's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bioteque's price. Additionally, you may evaluate how the addition of Bioteque to your portfolios can decrease your overall portfolio volatility.